Current Report Filing (8-k)
February 25 2019 - 6:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 5, 2019
MEDICAL
INNOVATION HOLDINGS, INC.
(Exact
name of Registrant as specified in its charter)
Colorado
|
000-27211
|
84-1469319
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
5805
State Bridge Road, Suite G-328, Duluth, GA 30097
(Address
of Principal Executive Offices)
(866)
883-3793
(Registrant's
Telephone Number, Including Area Code)
_______________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
[_] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[_] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
Emerging
Growth Company
x
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
SECTION
5 – CORPORATE GOVERNANCE AND MANAGEMENT
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers
On February
5, 2019, Bart Siegel resigned as a member of the Board of Directors of our Company due to health reasons. Concurrently, the Board
authorized and accepted the appointment of Raymond Demotte and Redgie Green to the Board of Directors. Mr. Demotte was also appointed
Chief Financial Officer effective immediately.
Biographical
information regarding the new appointments are as follows:
RAYMOND
DeMOTTE, Chief Financial Officer and Director
Mr.
DeMotte served as Chief Executive Officer, President and as a member of the board of directors for South American Gold from September
3, 2010 until February 14, 2012. Mr. DeMotte served as Vice President of Business Development and as a director of Boulder
Hill Mines, Inc., a private mineral exploration company based in Idaho, and previously was President and a director of Castle Creek
Silver, Inc., a private mineral exploration company based in Idaho from June 2008 to February 2014. Mr. Demote served as
President and CEO of Sterling Mining Company from November 1998 to May 2008 and as a director of Sterling Mining Company from November
2008 to February 2009. Mr. DeMotte also served as a director and served on the audit committee for Silverfield Resources,
Inc. and Wescan Uranium, Inc.Mr De Motte from 2016 has taught classes at the university level in History and Business.Mr. DeMotte
holds a Bachelor of Science in International Business Administration from the American College of Switzerland. a Master of Business
Administration from Golden Gate University in San Francisco, California, and a Master of Arts in Classical History from the American
Public University, Charles Town, West Virginia. Mr. DeMotte is a member of the Society for the Promotion of Roman Studies and the
Northumbrian Language Society.
We
believe that Mr. DeMotte’s extensive business expertise, his experience in the mining industry and international business
and his roles as President and Chief Executive Officer gives him the qualifications and skills to serve as an officer and Director.
REDGIE
GREEN, Director
Mr.
Green was a director and officer of Fuquan Financial Co (fka Southwestern Water Exploration, Inc.) February 2017 through March
7, 2018. Mr. Green was a director of Golden Dragon Holding Corp. from 2006 to 2014. Mr. Green has served as the President
and Chief Executive Officer (until 2014) and a Director of Legacy Technology Holdings, Inc. since October 2010 and as a Director
of Momentum BioFuels, Inc. since May 2012. Mr. Green was co-owner and operator of Green's B&R Enterprises, a wholesale
donut baker from 1983 to 1990. He has been an active investor in small capital and high-tech adventures since 1987. Mr. Green
has been a director of IntreOrg Systems, Inc. from March 2008 until October 2017 and International Paintball, Inc. from 2008
to 2012. Mr. Green received a B.S. in Business Administration from the University of Colorado. He was CEO and director of Capital
Franchising Inc. from 2012 to 2014 and then again he was an officer and director from 2014 to 2015 (as “Jubilee 4Gold, Inc.”).
He was the President and director of Strategic Pharma Information Sciences, Inc. from May 2017 to January 2018.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Medical
Innovation Holdings, Inc.
By:
/s/
Arturo Sanchez
____________________
Arturo
Sanchez
Title:
CEO
Date:
February 19, 2019